Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

Journal of Clinical Oncology

Volumn 22, Issue 3, 2004, Pages 439-445

  Amling, Christopher L ^a   Riffenburgh, Robert H ^a   Sun, Leon ^a   Moul, Judd W ^a   Lance, Raymond S ^a   Kusuda, Leo ^a   Sexton, Wade J ^a   Soderdahl, Douglas W ^a   Donahue, Timothy F ^a   Foley, John P ^a   Chung, Andrew K ^a   McLeod, David G ^a  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BODY MASS; CANCER RECURRENCE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILITARY SERVICE; MULTIVARIATE ANALYSIS; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; BLOOD; CANCER STAGING; CAUCASIAN; CLINICAL TRIAL; ETHNOLOGY; MULTICENTER STUDY; NEGRO; PROGNOSIS; PROSTATE TUMOR; SOLDIER; TUMOR RECURRENCE;

AFRICAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MILITARY PERSONNEL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OBESITY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 1442265961     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.03.132     Document Type: Article

References (42)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1995. Int J Cancer 54:594-606, 1993
2. Jemal A, Thomas A, Murray T, et al: Cancer statistics 2002. CA Cancer J Clin 52:23-47, 2002
3. Ghafoor A, Jemal A, Cokkinides V, et al: Cancer statistics for African Americans. CA Cancer J Clin 52:326-341, 2002
4. Wynder EL, Fujita Y, Harris RE, et al: Comparative epidemiology of cancer between the United States and Japan: A second look. Cancer 67:746-763, 1991
5. Breslow N, Chan CW, Dhom G, et al: Latent carcinoma of the prostate in seven areas. Int J Cancer 20:680-688, 1977
6. Yatani R, Chigusa I, Akazaki K, et al: Geographic pathology of latent prostatic carcinoma. Int J Cancer 29:611-616, 1982
7. Calle EE, Rodriquez C, Walker-Thurmond K, et al: Overweight, obesity and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638, 2003
8. Kolonel LN: Nutrition and prostate cancer. Cancer Causes Control 7:83-94, 1996
9. Whittemore AS, Kolonel LN, Wu AH, et al: Prostate cancer in relation to diet physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87:652-661, 1995
10. Giovannucci E, Rimm EB, Colditz GA, et al: A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85:1571-1579, 1993
11. Kolonel LN, Yoshizawa CN, Hankin JH, et al: Diet and prostate cancer: A case-control study in Hawaii. Am J Epidemiol 127:999-1012, 1988
12. West DW, Slattery ML, Robison LM, et al: Adult dietary intake and prostate cancer risk in Utah: A case-control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85-94, 1991
13. Ross RK, Shimizu H, Paganini-Hill A, et al: Case control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst 78:869-874, 1987
14. Walker AR, Walker BF, Tsotetsi NG, et al: Case-control study of prostate cancer in black patients in Soweto, South Africa. Br J Cancer 65:438-441, 1992
15. Mydlo JH, Kanter JL, Kral JG, et al: The role of obesity and diet in urological carcinogenesis. BJU Int 84:225-234, 1999
16. Pasquali R, Casimirri F, Cantobelli S, et al: Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40: 101-104, 1991
17. Wu AH, Whittemore AS, Kolonel LN, et al: Serum androgens and sex hormone binding globulins in relation to lifestyle factors in older African-American, White and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev 4:735-741, 1995
18. Ross RK, Henderson BE: Do diet and androgens alter prostate cancer risk via a common etiologic pathway? J Natl Cancer Inst 86: 252-254, 1994
19. Gann PH, Hennekens CH, Ma J, et al: Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88:1118-1126, 1996
20. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143, 1991
21. Cohen P, Peehl DM, Rosenfeld RG: The IGF axis in the prostate. Horm Metab Res 26:81-84, 1994
22. Chan JM, Stamfer MJ, Giovannucci E, et al: Plasma insulin-like growth factor 1 in relation to prostate cancer risk: A prospective study. Science 279:563-566, 1998
23. Considine RV, Sinha MK, Heiman ML, et al: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295, 1996
24. Severson RK, Grove JS, Nomura AM, et al: Body mass and prostate cancer: A prospective study. BMJ 297:713-715, 1988
25. Giovannucci E, Rimm EB, Stampfer MJ, et al: Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6:557-563, 1997
26. Schuurman AG, Goldbohm RA, Dorant E, et al: Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151:541-549, 2000
27. Putnam SD, Cerhan JR, Parker AS, et al: Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 10:361-369, 2000
28. Hsing AW, Deng J, Sesterhenn IA, et al: Body size and prostate cancer: A population-based case-control study in China. Cancer Epidemiol Biomarkers Prev 9:1335-1341, 2000
29. Lee IM, Sesso HD, Paffenbarger RS: A prospective study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control 12:187-193, 2001
30. Andersson SO, Wolk A, Bergstrom HA, et al: Body size and prostate cancer: A 20-year follow-up study among 135,006 Swedish construction workers. J Natl Cancer Inst 89:385-389, 1997
31. Snowdon DA, Phillips RL, Choi W: Diet, obesity, and risk of fatal prostate cancer. Am J Epidemiol 120:244-250, 1984
32. Rodriguez C, Patel AV, Calle EE, et al: Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10:345-353, 2001
33. Tarman GJ, Kane CJ, Moul JW, et al: Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system. Urology 56:1016-1020, 2000
34. Hunter CP: Epidemiology, stage at diagnosis, and tumor biology of breast carcinoma in multiracial and multiethnic populations. Cancer 88:1193-1202, 2000
35. Dignam JJ: Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin 50:50-64, 2000
36. Jones BA, Stanislav KV, McCrea Curnen MG, et al: Severe obesity as an explanatory factor for the black/white difference in stage at diagnosis of breast cancer. Am J Epidemiol 146:394-504, 1997
37. Hayes RB, Ziegler RG, Gridley G, et al: Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol Biomarkers Prev 8:25-34, 1999
38. World Health Organization. Obesity: Preventing and Managing the Global Epidemic-Report of a WHO Consultation on Obesity. Geneva, Switzerland, World Health Organization, 1997
39. Sierra-Honigmann MR, Nath AK, Murakami C, et al: Biological action of leptin as an angiogenic factor. Science 281:1683-1686, 1998
40. Weidner N, Carroll PR, Flax J, et al: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 143:401-409, 1993
41. Ogden CL, Flegal KM, Carroll MD, et al: Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288:1728-1732, 2002
42. Gapstur SM, Gann PH, Kopp P, et al: Serum androgen concentrations in young men: A longitudinal analysis of associations with age, obesity, and race-The CARDIA Male Hormone Study. Cancer Epidemiol Biomarkers Prev 11:1041-1047, 2002